venBio Global Strategic Fund II L.P., 10% Owner at Apellis Pharmaceuticals, Inc. (APLS), bought 3,579,305 shares at $14.00 ($1.8M) on 2017-11-13, disclosed to the SEC on 2017-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,451,790 | $0 | 0.0% |
| 2 | $14.00 | 127,515 | $1.8M | 100.0% |
| Total | $0.50 avg | 3,579,305 | $1.8M | 100% |
| Filing → |
| CMPI | SELL | 2022-04-29 | $3.2M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |